Sector: MedicalLABOPHARM INC (NASDAQ: DDSS)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 274 |
Technical : | 277 |
Performance : | 274 |
Overall: | 301 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 243 |
Technical : | 136 |
Performance : | 225 |
Overall: | 246 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 239 |
Technical : | 139 |
Performance : | 264 |
Overall: | 260 |
Number of Stocks: | 306 |
Headlines
- Labopharm fera une présentation à la conférence Dundee sur la croissance émergente
Nov 20, 2009 07:02 AM | DDS, DDSS
- Labopharm to present at Dundee Emerging Growth Summit
Nov 20, 2009 07:01 AM | DDS, DDSS
- La formulation innovante de trazodone de Labopharm fait l'objet d'une publication dans une revue médicale
Nov 10, 2009 12:47 PM | DDS, DDSS
- Labopharm's novel trazodone formulation subject of publication in peer-reviewed medical journal
Nov 10, 2009 12:46 PM | DDS, DDSS
- Labopharm annonce ses résultats du troisième trimestre de l'exercice 2009
Nov 06, 2009 08:36 AM | DDS, DDSS
- Labopharm to host conference call Friday, November 6, 2009 at 10:00 a.m. (ET)
Oct 29, 2009 07:44 AM | DDS, DDSS
- Labopharm tiendra une conférence téléphonique le vendredi 6 novembre 2009 à 10 h 00 (HE)
Oct 29, 2009 07:44 AM | DDS, DDSS
- Labopharm conclut une entente avec Grunenthal pour la distribution et l'approvisionnement du tramadol-acétaminophène à deux prises quotidiennes dans un certain nombre de pays européens
Oct 08, 2009 08:12 AM | DDS, DDSS
- Labopharm completes distribution and supply agreement with Grunenthal for twice-daily tramadol-acetaminophen for a number of European countries
Oct 08, 2009 08:03 AM | DDS, DDSS
- Labopharm annonce que son fournisseur de l'IPA du trazodone a répondu aux points soulevés par la FDA au niveau de la fabrication
Oct 07, 2009 08:46 AM | DDS, DDSS
- Hercules Technology Growth Capital Announces Three Portfolio Companies That Reached Multi-Million Dollar Milestones
Oct 20, 2009 02:51 PM | CPWR, DDSS, HTGC
- Labopharm's response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
Aug 25, 2009 04:31 PM | DDS, DDSS
- Labopharm comments on judgment in Purdue patent litigation
Aug 17, 2009 08:51 AM | DDS, DDSS
- Labopharm submits response to FDA for novel antidepressant
Aug 11, 2009 12:25 PM | DDS, DDSS
- Labopharm files New Drug Submission with Health Canada for novel antidepressant
Aug 05, 2009 07:01 AM | DDS, DDSS
- Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
Jul 30, 2009 07:00 AM | DDS, DDSS
- Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
Jul 27, 2009 07:00 AM | DDS, DDSS
- InvestorSoup.com Issues Trading Outlook for Labopharm Inc.
Jul 22, 2009 06:51 AM | BVF, DDSS, DEPO, IPXL, WPI
- Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
Jul 20, 2009 09:25 AM | DDS, DDSS
- Labopharm amends debt facility agreement with Hercules
Jun 25, 2009 07:00 AM | DDS, DDSS
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
DDSS
|
Compare to S&P
|
| YTD |
-18.13 %
|
-32.37 %
|
| 4 Weeks |
-12.86 %
|
-13.33 %
|
| 12 Weeks |
-5.70 %
|
-11.51 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -37.50 %
|
|
EPS Growth in Last Year: -10.00 %
|
|
Sales Growth in Last Quarter: 6.47 %
|
|
Sales Growth in Last Quarter: -31.46 %
|
|
